• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯阿西尔地区的 耐药模式:一项基于医院的十年研究。

Resistance Pattern of in Aseer Region, Saudi Arabia: A Ten-Year Hospital-Based Study.

机构信息

Preventive Medicine and Public Health Physician, Ministry of Health, Abha 62515, Saudi Arabia.

Community Medicine Consultant, Ministry of Health, Abha 62515, Saudi Arabia.

出版信息

Medicina (Kaunas). 2024 Aug 19;60(8):1344. doi: 10.3390/medicina60081344.

DOI:10.3390/medicina60081344
PMID:39202625
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11356269/
Abstract

The frequency of multidrug-resistant Klebsiella pneumoniae (MDRKP) has dramatically increased worldwide in recent decades, posing an urgent threat to public health. The aim of this study was to assess the extent of in the Aseer region and explore the corresponding antimicrobial resistance profile over the last ten years. A record-based retrospective study was conducted in a tertiary hospital during the period of 2013 to 2022. The study targeted laboratory samples taken from patients admitted to the hospital and sent for culturing. We included only samples taken from the patient and confirmed by the lab. Data were extracted using a pre-structured data extraction sheet to avoid data-collection bias and confirm the inter-rater precision. Statistical Package for Social Sciences (SPSS) version 26 was employed for statistical analysis. All relationships were tested using Pearson X test for categorical data or chi-square for linear trend for resistance rate over years. : We obtained 3921 samples of isolated out of 28,420 bacterial samples. The isolation rate began at 11.3% in 2013, decreased to 6.1% in 2016, and then increased to a peak of 16.3% in 2021, before slightly decreasing to 12.8% in 2022. In total, 23.7% of samples were identified in urine samples, 19% in sputum samples, 14% in wound samples, and 11.7% in blood samples. The overall antibiotic resistance rate of from 2013 to 2022 showed a significant increase, particularly during 2020 and 2021, before decreasing again in 2022. The resistance rate decreased from 22.2% in 2013 to 18.6% in 2016 and increased to 54.6% and 56.4% during 2020 and 2021, respectively ( = 0.039) We observed a significant shift in resistance for some antibiotics during the study period, highlighting the urgent need for enhanced antimicrobial stewardship and infection-control measures.

摘要

近年来,全球范围内多药耐药肺炎克雷伯菌(MDRKP)的频率显著增加,对公共卫生构成了紧迫威胁。本研究旨在评估过去十年阿西尔地区的流行程度,并探讨相应的抗生素耐药谱。

本研究采用回顾性记录研究方法,在 2013 年至 2022 年期间在一家三级医院进行。研究对象为医院收治并送检培养的患者的实验室样本。我们只纳入了实验室确认的患者样本。使用预先设计的数据提取表提取数据,以避免数据收集偏倚并确认组内一致性。采用统计软件包(SPSS)版本 26 进行统计分析。对于分类数据,采用 Pearson X 检验检验所有关系,对于线性趋势检验,采用卡方检验检验耐药率随年份的变化。

我们从 28420 个细菌样本中获得了 3921 个分离的肺炎克雷伯菌样本。2013 年的分离率为 11.3%,2016 年降至 6.1%,2021 年达到 16.3%的峰值,随后在 2022 年略有下降至 12.8%。总的来说,尿液样本中 23.7%的样本、痰液样本中 19%的样本、伤口样本中 14%的样本和血液样本中 11.7%的样本鉴定为肺炎克雷伯菌。2013 年至 2022 年,肺炎克雷伯菌的总体抗生素耐药率呈显著上升趋势,特别是在 2020 年和 2021 年,然后在 2022 年再次下降。2013 年的耐药率为 22.2%,2016 年降至 18.6%,2020 年和 2021 年分别上升至 54.6%和 56.4%(=0.039)。我们观察到研究期间一些抗生素的耐药性发生了显著变化,这突出表明迫切需要加强抗菌药物管理和感染控制措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/1d49fcdf7c6a/medicina-60-01344-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/942274385b4b/medicina-60-01344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/39180c4258bc/medicina-60-01344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/21fad2da22b7/medicina-60-01344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/c423c4b17531/medicina-60-01344-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/bdbef616f106/medicina-60-01344-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/ae0103358d6a/medicina-60-01344-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/98b85829d444/medicina-60-01344-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/1d49fcdf7c6a/medicina-60-01344-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/942274385b4b/medicina-60-01344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/39180c4258bc/medicina-60-01344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/21fad2da22b7/medicina-60-01344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/c423c4b17531/medicina-60-01344-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/bdbef616f106/medicina-60-01344-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/ae0103358d6a/medicina-60-01344-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/98b85829d444/medicina-60-01344-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04af/11356269/1d49fcdf7c6a/medicina-60-01344-g008.jpg

相似文献

1
Resistance Pattern of in Aseer Region, Saudi Arabia: A Ten-Year Hospital-Based Study.沙特阿拉伯阿西尔地区的 耐药模式:一项基于医院的十年研究。
Medicina (Kaunas). 2024 Aug 19;60(8):1344. doi: 10.3390/medicina60081344.
2
Antimicrobial resistance of Klebsiella pneumoniae in a Saudi Arabian hospital: results of a 6-year surveillance study, 1998-2003.沙特一家医院肺炎克雷伯菌的耐药性:1998 - 2003年6年监测研究结果
J Infect Chemother. 2007 Aug;13(4):230-4. doi: 10.1007/s10156-007-0532-9. Epub 2007 Aug 27.
3
Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.沙特阿拉伯武装部队医院肺炎克雷伯菌临床分离株的患病率、抗生素敏感性模式及超广谱β-内酰胺酶的产生情况
J Coll Physicians Surg Pak. 2009 Apr;19(4):264-5.
4
ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia.沙特阿拉伯一家三级医疗医院中产超广谱β-内酰胺酶的大肠杆菌和肺炎克雷伯菌
J Infect Dev Ctries. 2014 Sep 12;8(9):1129-36. doi: 10.3855/jidc.4292.
5
Klebsiella pneumoniae bacteraemia epidemiology: resistance profiles and clinical outcome of King Fahad Medical City isolates, Riyadh, Saudi Arabia.肺炎克雷伯菌菌血症的流行病学:沙特阿拉伯利雅得法赫德国王医疗城分离株的耐药谱和临床结局。
BMC Infect Dis. 2023 Sep 5;23(1):579. doi: 10.1186/s12879-023-08563-8.
6
Genomic analysis of the first KPC-producing Klebsiella pneumoniae isolated from a patient in Riyadh: A new public health concern in Saudi Arabia.利雅得首例产 KPC 肺炎克雷伯菌的基因组分析:沙特阿拉伯新的公共卫生关注点。
J Infect Public Health. 2020 Apr;13(4):647-650. doi: 10.1016/j.jiph.2020.01.003. Epub 2020 Feb 14.
7
Carbapenem non-susceptibility of isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS).2011 年至 2016 年德国抗菌药物耐药性监测(ARS)医院分离株的碳青霉烯类药物不敏感性数据。
Antimicrob Resist Infect Control. 2018 Jun 5;7:71. doi: 10.1186/s13756-018-0362-9. eCollection 2018.
8
Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.沙特阿拉伯朱夫地区血流感染的病原菌谱和革兰氏阴性菌的耐药模式。
PLoS One. 2020 Jun 9;15(6):e0233704. doi: 10.1371/journal.pone.0233704. eCollection 2020.
9
Extended-spectrum beta-lactamase-producing and : insights from a tertiary hospital in Southern Thailand.产超广谱β-内酰胺酶和:来自泰国南部一家三级医院的见解。
Microbiol Spectr. 2024 Jul 2;12(7):e0021324. doi: 10.1128/spectrum.00213-24. Epub 2024 May 29.
10
Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance.沙特阿拉伯的肠杆菌感染:携带三重碳青霉烯酶基因耐药性的肺炎克雷伯菌的首次记录。
J Infect Dev Ctries. 2019 Apr 30;13(4):334-341. doi: 10.3855/jidc.11056.

本文引用的文献

1
Microbiological profile of patients treated for postoperative peritonitis: temporal trends 1999-2019.术后腹膜炎治疗患者的微生物学特征:1999-2019 年的时间趋势。
World J Emerg Surg. 2023 Dec 19;18(1):58. doi: 10.1186/s13017-023-00528-1.
2
Antimicrobial resistance pattern of Klebsiella isolated from various clinical samples in Ethiopia: a systematic review and meta-analysis.从埃塞俄比亚各种临床样本中分离的肺炎克雷伯菌的抗菌药物耐药模式:系统评价和荟萃分析。
BMC Infect Dis. 2023 Oct 2;23(1):643. doi: 10.1186/s12879-023-08633-x.
3
Carbapenem-Resistant in COVID-19 Era-Challenges and Solutions.
新冠疫情时代的碳青霉烯类耐药——挑战与解决方案
Antibiotics (Basel). 2023 Aug 4;12(8):1285. doi: 10.3390/antibiotics12081285.
4
Changing Trend in the Antibiotic Resistance Pattern of Klebsiella Pneumonia Isolated From Endotracheal Aspirate Samples of ICU Patients of a Tertiary Care Hospital in North India.印度北部一家三级护理医院重症监护病房患者气管内吸出物样本中分离出的肺炎克雷伯菌抗生素耐药模式的变化趋势
Cureus. 2023 Mar 17;15(3):e36317. doi: 10.7759/cureus.36317. eCollection 2023 Mar.
5
Prevalence and Antibiogram Pattern of in a Tertiary Care Hospital in Makkah, Saudi Arabia: An 11-Year Experience.沙特阿拉伯麦加一家三级护理医院的[具体内容缺失]的患病率及抗菌谱模式:11年经验。
Antibiotics (Basel). 2023 Jan 12;12(1):164. doi: 10.3390/antibiotics12010164.
6
Exploring the Antibiotic Resistance Profile of Clinical Isolates in Portugal.探索葡萄牙临床分离株的抗生素耐药谱。
Antibiotics (Basel). 2022 Nov 13;11(11):1613. doi: 10.3390/antibiotics11111613.
7
Antimicrobial Resistance Patterns, Extended-Spectrum Beta-Lactamase Production, and Associated Risk Factors of Species among UTI-Suspected Patients at Bahir Dar City, Northwest Ethiopia.埃塞俄比亚西北部巴赫达尔市疑似尿路感染患者中细菌的耐药模式、超广谱β-内酰胺酶产生情况及相关危险因素
Int J Microbiol. 2022 Mar 18;2022:8216545. doi: 10.1155/2022/8216545. eCollection 2022.
8
Clinical Epidemiology, Risk Factors, and Control Strategies of Infection.感染的临床流行病学、危险因素及控制策略
Front Microbiol. 2021 Dec 22;12:750662. doi: 10.3389/fmicb.2021.750662. eCollection 2021.
9
Global Prevalence of Nosocomial Multidrug-Resistant : A Systematic Review and Meta-Analysis.医院获得性多重耐药的全球患病率:一项系统评价与荟萃分析。
Antibiotics (Basel). 2021 Dec 8;10(12):1508. doi: 10.3390/antibiotics10121508.
10
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of .临床分离株 的毒力因子、抗生素耐药模式和分子分型。
Expert Rev Anti Infect Ther. 2022 Mar;20(3):463-472. doi: 10.1080/14787210.2022.1990040. Epub 2021 Oct 28.